The disease-defeating contraceptives were found to be defective by the Pharmaceuticals Fund and Supply Agency (PFSA), a government body, according to a report on local station Radio Fana.
Agency director Meskele Lera said action was under way to force the condom supplier to, "reimburse the money and cover all costs in the discarding process."
The USD 2 million (1.8 million euros) worth of condoms were reportedly manufactured by an unnamed Indian company and paid for by the Global Fund to Fight AIDS, Tuberculosis and Malaria but failed basic tests.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
